| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 20 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OMGAQ | Omega Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:20 |
| OMGAQ | Omega Therapeutics, Inc. | 28 Aug 2023 | 1 | $0 | 4 | Director | 29 Aug 2023, 16:32 |
| OMGAQ | Omega Therapeutics, Inc. | 28 Aug 2023 | 0 | $0 | 3 | Director | 29 Aug 2023, 16:30 |